Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02732834 · ClinicalTrials.gov registry record
Clinician-Patient Communication in Lung Cancer Care
A clinical trial of Lung Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 294
- Enrollment target
- 7
- Study locations
NCT02732834: Active study of Lung Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02732834 is a study of Lung Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 294 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (69% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02732834, a study of Lung Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 294 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to better understand communication between patients with lung cancer and their clinicians. The investigators are also interested in patient's perceptions of the quality of communication with his/her clinician and how these perceptions may impact patient outcomes. The clinician participating in this study and has given us permission to approach his/her eligible patients for study participation.
Primary Outcome
interview along with patient-reported data from the post-consultation questionnaire will be used.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Patient Interview
- BEHAVIORAL Audio recordings of clinical consultations
- BEHAVIORAL 2-hour empathic communication skills training
Study Locations (7)
New York
- Memorial Sloan Kettering Commack (Consent and follow-up only) - Commack
- Memorial Sloan Kettering Westchester (Consent and follow-up only) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Consent and Follow-Up only) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent and follow-up only) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent and follow-up only) - Middletown
- Memorial Sloan Kettering Bergen (Consent and follow-up only) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 2016-01 |
| Est. Completion | 2027-01 |
What the registry record for NCT02732834 still lists
NCT02732834 is an observational study that tracks outcomes without assigning an intervention. The registered 294 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire is the first listed.
NCT02732834 lists 7 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT02732834 about?
NCT02732834 is a clinical study titled "Clinician-Patient Communication in Lung Cancer Care". The purpose of this study is to better understand communication between patients with lung cancer and their clinicians. The investigators are also interested in patient's perceptions of the quality of communication with his/her clinician and how these perceptions may impact patient outcomes. The cli...
What is the current status of trial NCT02732834?
This trial is currently active not recruiting. The enrollment target is 294 participants. The study started on 2016-01. Estimated completion is 2027-01.
What conditions does trial NCT02732834 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT02732834?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Patient Interview (BEHAVIORAL), Audio recordings of clinical consultations (BEHAVIORAL), 2-hour empathic communication skills training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02732834?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02732834 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02732834's enrollment target sits among peer trials
294 103rd of 409 higher than 307 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia